REQUEST A DEMO
Total
USD $0.00
Search more companies

Merix Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Merix Laboratories Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Merix Laboratories Private Limited is an unlisted company, incorporated on 13/04/2006. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24230TG2006PTC049825 and registration number is 049825. The company is a trade company, it is engaged in retail trading.

Legal Address
Merix Square, 5Th Floor, H.No.04-009/Nr, Pet Basheerabad(V), Quthbullapur(M)
Hyderabad; Telangana; Postal Code: 500055

Contact Details: Purchase the Merix Laboratories Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Merix Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Merix Laboratories Private Limited report to view the information.
Financial Auditors:
Purchase the Merix Laboratories Private Limited report to view the information.
Incorporation Date:
April 13, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Merix Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
124.44%
Total operating revenue
105.65%
Operating profit (EBIT)
39.88%
EBITDA
37.24%
Net Profit (Loss) for the Period
34.23%
Total assets
23.95%
Total equity
21.72%
Operating Profit Margin (ROS)
-10.14%
Net Profit Margin
-8.66%
Return on Equity (ROE)
1.67%
Debt to Equity Ratio
-0.27%
Quick Ratio
-0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?